RGEN(Repligen Corporation) 的财务报表:医疗保健,医疗仪器与耗材。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $670.53M | $801.54M | $632.36M | $634.44M | $738.26M |
| 毛利润 | $391.25M | $455.71M | $278.44M | $274.64M | $386.25M |
| 营业利润 | $167.25M | $224.67M | $47.70M | −$35.11M | $55.17M |
| 净利润 | $128.29M | $185.96M | $35.60M | −$25.51M | $48.89M |
| 经营现金流 | $119.02M | $172.08M | $113.92M | $175.39M | $117.42M |
| 自由现金流 | $51.93M | $87.25M | $77.70M | $149.72M | $93.90M |
| 摊薄每股收益 | $2.24 | $3.24 | $0.63 | $-0.46 | $0.86 |